Cargando…
Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome
BACKGROUND: Fecal microbiota transplantation (FMT) has been shown to highly effective in the treatment of recurrent or refractory Clostridioides difficile infection (rCDI) in many countries of the world. Not until 2018, Ministry of Health and Welfare, Taiwan approved the application of FMT for rCDI...
Autores principales: | Yeh, Yuan-Ming, Cheng, Hao-Tsai, Le, Puo-Hsien, Chen, Chien-Chang, Kuo, Chia-Jung, Chen, Chyi-Liang, Chiu, Cheng-Tang, Chiu, Cheng-Hsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421926/ https://www.ncbi.nlm.nih.gov/pubmed/34118466 http://dx.doi.org/10.1016/j.bj.2021.06.001 |
Ejemplares similares
-
Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023) -
Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021) -
Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
por: Chiu, Chun-Wei, et al.
Publicado: (2021) -
Current and future applications of fecal microbiota transplantation for children
por: Chen, Chien-Chang, et al.
Publicado: (2022) -
Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)